Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profilingUltan McDermott, Jeffrey Settleman, Raul Raudales et al.|Proceedings of the National Academy of Sciences|2007Cited by 358
The T790M “gatekeeper” mutation in <i>EGFR</i> mediates resistance to low concentrations of an irreversible EGFR inhibitorNadia Godin-Heymann, Daniel A. Haber, Jennifer Lamb et al.|Molecular Cancer Therapeutics|2008Cited by 205